Printer Friendly

Mini puberty and its interpretation.

Abstract

Gonadotropins which are high in the middle of the fetal life are measured to be considerably low in the cord blood and estrogen is found to be high in the cord blood. Gonodotropins are supressed by estrogen. After delivery, the hypothalamo-pituitary-gonadal axis is activated when estrogen is eliminated and a hormone profile which reaches pubertal levels is established. These changes are called mini puberty. In boys, long-term testicular functions and sperm production are regulated with mini puberty and mini puberty contributes to masculinization of the brain. The role of mini puberty in female newborns is not known. Central hypogonadism, Turner syndrome and ovarian hyperstimulation in preterm babies may be diagnosed with evaluation of mini puberty. In this article, mini puberty and related problems were reviewed and the importance of this issue was emphasized. (Turk Ped Ars 2014; 49: 186-91)

Key words: Mini puberty, newborn, interpretation

Gonadotropins which are at high levels in the middle of the fetal life are considerably low in the cord blood and estrogen is measured to be high. The reason for this is the inhibitory effect of increased estrogen levels in the circulation arising from the placenta on gonadotropin releasing hormone (GnRH) pulse generator and pituitary gonadotropins (1, 2). In male fetuses, testosterone levels probably contribute additionally to inhibition (3). Gonadotropin inhibition discontinues with placental seperation, the hypothalamo-pituitary-gonadal axis is activated and the hormonal changes which occur are identified as mini puberty (2, 4). The activation of the hypothalamo-pituitary-gonadal axis reach a peak level approximately in the 6-8th week after delivery. In this period, the levels of sex steroids are similar to early-middle pubertal levels, but their peripheral effects are not realized (4).

In boys, the level of luteinizing hormone (LH) increases approximately 10-fold in the minutes following delivery and the level of tesosterone increases. This state lasts approximately for 12 hours (5, 6). The increase in follicle stimulating hormone (FSH) and LH continues in the second week after delivery, reaches a peak in the 4-1[0.sup.th] week, decreases in the [6.sup.th] month to the prepubertal levels. The level of testosterone increased by release of luteinizing hormone reaches a peak at around the third month and decreases to the prepubertal levels in the 6-[9.sup.th] months (1, 7, 8). Similarly, the levels of 17-hydroxyprogesteron and androstenodione which are increased with testosterone decrease with reduction of the level of LH (2). After delivery, an increase in the number of Leydig cells starts. This increase reaches a peak in the third month. Afterwards, reduction and apopytosis occur in fetal and infantile Leydig cells (9-11). Inhibin-B is a glycoprotein belonging to the family of transforming growth factor beta (TGF-[beta]) and is released from Sertoli cells in the prepubertal period. It is considered an indicator of sertoli cell function in prepubertal male children, but it does not reflect the number and function of germ cells. Inhibin-B acts as a regulator of release of FSH (1). Inhibin-B can be measured in the cord blood, it increases after delivery, reaches a peak in the 4-1[2.sup.th] month (exceeds the male adult level). It is at a considerably low level at the age of 3-9 years and increases again with the initiation of the puberty (3, 7). Serum inhibin-B levels are low in cases of hypogonadotropic hypogonadism (1, 12).

Anti-Mullerian hormone (AMH) is a glycoprotein released from the sertoli cells starting from the fetal period. It is found in the cord blood and its level increases in the first 30 months after delivery. It reaches a peak in the [6.sup.th]month, starts to decrease in the childhood and decreases to considerably low levels in the pubertal period (13, 14). The level of AMH decreases in parallel to increased testosterone in the puberty.

In boys, both inhibin-B and AMH levels give an idea about the presence and function of Sertoli cells in the months following delivery and in the prepubertal period (1). In cases of bilateral criptorchidism, human chorionic gonadotropin hormone stimulation test can be performed to determine the presence and function of the testicles. However, it should be kept in mind that inhibin-B level may be normal and AMH may be low in "persistent Mullerian duct" syndrome, if there is AMH receptor unresponsiveness (1).

Conclusively, the testicular volume increases with elongation of the seminiferous tubules (6-fold until the age of one) with mini puberty which starts in the neonatal period and continues until the middle infancy (11, 15). It has been found that the mass of the Sertoli cells increases to constitute 85-95% of the seminefous tubules (16). It is thought that transient scrotal hairing which can be observed in the first year of life in boys is related with the physiological testosterone level which increases in the process of mini puberty (Figure 1) (17-19). The increase in the number and proliferation of Sertoli cells is determinative for spermatogenetic functions (20). The total number of germ cells increases approximately up to 100 days (50-150) (21). This increased mitotic activity allows the genocytes (non-primary reproductive cells) to transform into adult spermatogoniae which are considered stem cells for spermatogenesis between the 3[0.sup.th] and 8[0.sup.th] days in boys with increased gonadotropins and testosterone level (2, 20, 22). After the 6th month after delivery, the spermatogonia decrease in number in parallel to decreased gonadotropins. Activity in the GnRH pulse generator which lasts from the neonatal period to the middle infancy (mini puberty) is important for criptorchidism and the spermatogenic function and fertility in advanced years (20, 23-27). In addition, it is thought that increased level of testosterone provides masculinization of the brain an determines cognitive functions, sexual behavior and sexual orientation in relation (4, 28). In this period, the testicles increase from 0.5 mL to 1.5 mL, while penile growht is more insignificant. Lack of contribution to the penile growth and absence of other peripheral effects are explained by relative androgen insensitivity in the neonatal period and the first months of life (4). Similarly, acceleration in the bone age starts after the [6.sup.th]month after delivery in cases of congenital adrenal hyperplasia (29). In contrast to some views, it has been proposed that increased testosterone after delivery has no effect on masculine type of psychosexual development based on the information that subjects with Kallman syndrome can be masculinized by administration of pubertal testosterone (2). One of the interesting points is the fact that no increase in LH and testosterone is observed after delivery in cases of complete androgene insensitivity in contrast to partial androgene insensitivity (3, 30).

[FIGURE 1 OMITTED]

The FSH level in the circulation in girls is high in the middle period of pregnancy, decreases at delivery and increases again with activation of the hypothalamic-pituitary-gonadal axis. Production of AMH is limited in fetal ovaries. In female babies, transformation to estradiole increases with production of LH androstenodione which increases moderately after delivery and with increased FSH afterwards. The level of FSH is higher in girls. The hormones excluding follicle stimulating hormone decrease from the [6.sup.th]month after delivery (31). Increased FSH in girls continues until the age of 2-4 years. In girls, the level of estradiol is high in the 2-[4.sup.th] months after delivery (the levels may fluctuate) (31). Inhibin-B reaches a peak in the first four months and is maintained at the prepubertal level until the age of 2 years. In premature babies, increased FSH in the postnatal period is more exaggerated. Folliculogenesis and increase in AMH starts with increased FSH. However, this is observed later in preterm and near term babies compared to term babies (32). This explains increased FSH levels. In contrast to boys, it is not exactly known which superiorities mini puberty provides for girls. In a study conducted with girls aged approximately three months, inhibin-B was found to be 82 pg/mL, FSH was found to be 3.8 IU/L, LH was found to be 0.07 IU/L, estradiol was found to be 31 pM and SHBG was found to be 137 nM (32). FSH was found to be higher than 4.5 IU/L in 38% of the girls. In preterm babies, estradiol and inhibin-B were found to be higher. In addition, estradiol was higher in babies with intra-uterine growth retardation. Anti-Mullerian hormone and inhibin-B are high in the follicular phase and interpreted as ovarian function with counting of the antral follicles by ultrasonography.

Evaluation of mini puberty

The external genitalia are examined carefully after delivery. In male newborns, the penile lenght and testicular volume are measured with Prader orchimeter and US and hypospadias, criptorchidism, transverse testicular ectopy and inguinal hernia are noted. In girls and in babies whose external appearances are compatible with female gender, the labia majora, minora, hymen and urethra are examined. Gonad palpation is performed inside the labia or inguinal channel. Pigmentation in the genital region and nipples and other malformations are explored in both genders. Approximately after two months when mini puberty appears, FSH, LH, testosterone, estradiol, MAH, inhibin-B are measured and uterus-ovarian US is performed (Table 1, 2) (33). In term male babies, the level of testosterone increases to 60-400 ng/dL between the 2[0.sup.th] and 6[0.sup.th] days and decreases to the prepubertal level after the [7.sup.th] month (<3-10 ng/dL). In girls, the level of estradiol is high at delivery and decreases in the first week. It increases to 5-50 pg/mL between the 3[0.sup.th] and 6[0.sup.th] days. Afterwards, it decreases to the prepubertal level (below 15 pg/mL) (34). The uterus and ovaries are evaluated ultrasonographically in female babies. The dimensions of the uterus are increased due to the hormones crossing from the mother through the placenta (35, 36). The body of the uterus is more prominent compared to the cervix, the height of the uterus is 35 mm and the highest width is approximately 14 mm. The endometrium is apperent and echogenic. A small amount of fluid is found in the endometrial space in approximately 25% of the babies. The dimensions of the ovary in female newborns are larger compared to the childhood (approximately 1 mL). The size of the ovary is measured to be 1 mL until the age of one and 0.67 mL in the second year (37). In 84% of the babies, follicles the diameters of which do not exceed 1 cm are found from the neonatal period to the age of 2 years. The same finding is observed with a rate of 68% in girls aged between 2 and 6 years (38).

Problems related with mini puberty

1) If there is hypogonadotropic hypogonadism in boys, decreased FSH, testosterone and inhibin-B is found in addition to micropenis (strecthed penis <2.5 cm) and criptorchidism; LH may be inmeasurably low or may show low amplitude pulses. A blunted response is obtained in the gonadotropin releasing hormone test. Hypogonad-otropism may be found solely in the spectrum of Kallmann syndrome, DAX-1 mutation, multiple pituitary hormone deficiency. With this objective, pituitary and cranial magnetic resonance imaging, pituitary hormone tests and genetic tests may be performed. A picture of hypergonadotropism is observed in cases of gonadal agenesis (2). Gonadotropin treatment starting from the newborn period and allowance of testicular function by mini puberty created are recommended in cases of congenital hypogonadotropic hypogonadism (39).

2) The most important cause of the picture of hypogonadism is Turner syndrome. In babies with Turner syndrome, low birth weight, edema on hands and feet, weblike neck, inverted and hyperteloric nipples and pigmented nevi are noted (Figure 2). Aort coarctation and horseshoe kidney may be found. The uterus is hypoplasic and streak ovaries are observed on ultrasonography. A level of FSH below 40 is diagnostic, but it may not always be increased (40). Luteinizing hormone is normal and estradiol is low.

3) Excessive ovarian stimulation sydrome in preterm babies: This syndrome was reported by Sedin et al. (41) in 1985 for the first time in four preterm babies with a gestational age of 24-28 weeks. Edema in the vulva, hypogastric area and thigh was was noted in the postconceptional 36-3[9.sup.th] weeks (Figure 3). The investigations performed revealed high gonadotropin levels in addition to multiple cysts in the ovaries on ultrasonography. Afterwards, nine cases were published by Starzyk et al. (42). In addition to the same laboratory and clinical findings, solitary or multiple ovarian cysts with a mean diameter of 21 mm were found. Increase in gonadotropins was observed with GnRH test in a portion of the cases. Breast growht may be added to the picture in some cases (43). Solitary or monthly vaginal bleeding may occur in cases with a severe clinical course (44, 45). The pathophysiology of this picture which is observed in preterm babies is not known fully. It is thought that lack of maturation of the hypothalamo-pituitary-gonadal axis and lack of complete development of negative feedback mechanisms with discontinuation of placental steroids are involved (42, 46). It has been proposed that edema observed in the subjects is related with vascular endothelial growth factor released from the theca and granulosa cells (43, 47). It has been reported that fetal ovarian hyperstimulation may occur rarely (47). In a fetus with a gestational age of 35 weeks, macrosomy, placental thickenning, polyhydramniosis, large ovaries (right 17.8, left 16.3 mL), 2 ovarian cysts with large septae and abdominal distention were observed and the clinical picture was associated with the increased level of beta-hCG found in the mother.

[FIGURE 2 OMITTED]

In the diagnosis, increased FSH, LH, estradiol, increased dimensions of the ovaries and uterus and presence of ovarian cysts are directive in addition to the clinical picture.

[FIGURE 3 OMITTED]

The subjects should be followed up with clinical picture, FSH, LH, estradiol levels and ovarian ultrasonography. Ovarian cysts should be expected to become smaller gradually. Hence, reduction in the cysts are observed in the first month in 50% of the cases and at the end of the second month in 25% of the cases. The cysts may persist for longer than three months in 10% of the cases (42). Drainage by aspiration may be necessary because of the risk of tortion in solitary or multiple cysts with a diameter larger than 4-5 cm which do not get smaller (41). In severe cases where clinical regression is not observed, intracranial medroxy-progesteron acetate may be administered at a dose of 150 mg/[m.sup.2] with the aim of decreasing the synthesis of ovarian estradiol (42).

Peer-review: This manuscript was prepared by the invitation of the Editorial Board and its scientific evaluation was carried out by the Editorial Board.

Author Contributions: Concept - S.K., O.B, Design - S.K., O.B., Supervision - S.K., O.B.; Funding - S.K., O.B.; Analysis and/or Interpretation- S.K., O.B.; Literature review - S.K., O.B.; Writer - S.K., O.B.; Critical Review -S.K., O.B.; Other - S.K., O.B.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study has received no financial support.

References

(1.) Grumbach MM, Kaplan SL. The neuroendocrinology of human puberty: an ontogenic perspective. In: Grumbach MM, Sizonenko PC, Aubert ML, (eds). Control of the onset of puberty. Baltimore: Williams-Wilkins, 1990; 1-62.

(2.) Grumbach MM. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 2005; 90: 3122-7. [CrossRef]

(3.) Quigley CA. Editorial: The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2002; 87: 24-8. [CrossRef]

(4.) Saeger P. Definition, etiology, and evaluation of precocious puberty. Up To Date 2012.

(5.) Corbier P, Dehennin L, Castanier M, Mebazaa A, Edwards DA, Roffi J. Sexdifferences in serum luteinizing hormone and testosterone in the human neonateduring the first few hours after birth. J Clin Endocrinol Metab 1990; 71: 1344-8. [CrossRef]

(6.) de Zegher F, Devlieger H, Veldhuis JD. Pulsatile and sexually dimorphic secretion of luteinizing hormone in the human infant on the day of birth. Pediatr Res 1992; 32: 605-7. [CrossRef]

(7.) Forest MG. Pituitary gonadotropins and sex steroid secretion during the first two years of life. In: Grumbach MM, Sizonenko PC, Aubert ML, (eds). Control of the onset of puberty. Baltimore: Williams-Wilkins, 1990; 451-77.

(8.) Andersson AM, Toppari J, Haavisto AM, et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998; 83: 675-81. [CrossRef]

(9.) Nistal M, Paniagua R, Regadera J, Santamaria L, Amat P. A quantitative morphological study of human Leydig cells from birth to adulthood. Cell Tissue Res 1986; 246: 229-36. [CrossRef]

(10.) Lejeune H, Habert R, Saez JM. Origin, proliferation and differentiation of Leydig cells. J Mol Endocrinol 1998; 20: 1-25. [CrossRef]

(11.) Chemes HE. Infancy is not a quiescent period of testicular development. Int J Androl 2001; 24: 2-7. [CrossRef]

(12.) Main KM, Schmidt IM, Toppari J, Skakkebaek NE. Early postnatal treatment of hypogonadotropic hypogonadism with recombinant human FSH and LH. Eur J Endocrinol 2002; 146: 75-9. [CrossRef]

(13.) Rey RA, Belville C, Nihoul-Fekete C, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab 1999; 84: 627-31. [CrossRef]

(14.) Lee MM, Misra M, Donahoe PK, MacLaughlin DT. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 2003; 211: 91-8. [CrossRef]

(15.) Muller J, Skakkebaek NE. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys whosuffered from sudden death. Int J Androl 1983; 6: 143-56. [CrossRef]

(16.) Cortes D, Muller J, Skakkebaek NE. Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 1987; 10: 589-96. [CrossRef]

(17.) Diamond FB Jr, Shulman DI, Root AW. Scrotal hair in infancy. J Pediatr 1989; 114: 999-1001. [CrossRef]

(18.) Slyper AH, Esterly NB. Nonprogressive scrotal hair growth in two infants. Pediatr Dermatol 1993; 10: 34-5. [CrossRef]

(19.) Janus D, Wojcik M, Tyrawa K, Starzyk J. Transient isolated scrotal hair development in infancy. Clin Pediatr (Phila) 2013; 52: 628-32. [CrossRef]

(20.) Sharpe RM, McKinnell C, Kivlin C, Fisher JS. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003; 125: 769-84. [CrossRef]

(21.) Muller J, Skakkebaek NE. Fluctuations in the number of germ cells during the late foetal and early postnatal periods in boys. Acta Endocrinol (Copenh) 1984; 105: 271-4.

(22.) Hadziselimovic F, Hadziselimovic NO, Demougin P, Krey G, Oakeley EJ. Deficient expression of genes involved in the endogenous defense system againts transposons in cryptorchid boys with impaired mini-puberty. Sex Dev 2011; 5: 287-93. [CrossRef]

(23.) Berensztein EB, Sciara MI, Rivarola MA, Belgorosky A. Apoptosis and proliferation of human testicular somatic and germ cells during prepuberty: high rate of testicular growth in newborns mediated by decreased apoptosis. J Clin Endocrinol Metab 2002; 87: 5113-8. [CrossRef]

(24.) Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002; 87: 4128-36. [CrossRef]

(25.) Sharpe RM, Fraser HM, Brougham MF, et al. Role of the neonatal period of pituitary-testicular activity in germ cell proliferation and differentiation in the primate testis. Hum Reprod 2003; 18: 2110-7. [CrossRef]

(26.) Hadziselimovic F, Zivkovic D, Bica DT, Emmons LR. The impotance of mini-puberty for fertility in cryptorchidism. J Urol 2005; 174: 1536-9. [CrossRef]

(27.) Zivkovic D, Hadziselimovic F. Development of Sertoli cells during mini-puberty in normal and cryptochid testes. Urol Int 2009; 82: 89-91. [CrossRef]

(28.) Lewis K, Lee PA. Endocrinology of male puberty. Curr Opin Endocrinol Diabetes Obes 2009; 16: 5-9. [CrossRef]

(29.) Kuhns LR, and Finnstrom O. New standarts of ossification of the newborn. Radiology 1976; 119: 655-60. [CrossRef]

(30.) Bouvattier C, Carel JC, Lecointre C, et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 2002; 87: 29-32. [CrossRef]

(31.) Kuuri-Hanninen T, Kallio S, Seuri R, et al. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J Clin Endocrinol Metab 2011; 96: 3432-9. [CrossRef]

(32.) Chellakooty M, Schmidt IM, Haavisto AM, et al. Inhibin A, inhibin B, follcle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in healthy infant girls. J Clin Endocrinol Metab 2003; 88: 3515-20. [CrossRef]

(33.) Schmidt H, Schwarz HP. Serum concenrations of LH and FSH in the healthy newborn. Eur J Endocrinol 2000; 143: 213-5. [CrossRef]

(34.) ESOTERIX Laboratory Services, Endocrinology Expected Values, 2009.

(35.) Nussbaum AR, Sanders RC, Jones MD. Neonatal uterine morphology as seen on real-time US. Radiology 1986; 160: 641-3. [CrossRef]

(36.) Hata K, Nishigaki A, Makihara K, Takamiya O, Hata T, Kitao M. Ultrasonicevaluation of the normal uterus in the neonate. J Perinat Med 1989; 17: 313-7. [CrossRef]

(37.) Cohen HL, Shapiro MA, Mandel FS, Shapiro ML. Normal ovaries in neonates and infants: a sonographic study of 77 patients 1 day to 24 months old. AJR Am J Roentgenol 1993; 160: 583-6. [CrossRef]

(38.) Cohen HL, Eisenberg P, Mandel F, Haller JO. Ovarian cysts are common in premenarchal girls: a sonographic study of 101 children 2-12 years old. AJR Am J Roentgenol 1992; 159: 89-91. [CrossRef]

(39.) Bouvattier C, Maione L, Bouligand J, Dode C, Guiochon-Mantel A, Young J. Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism. Nat Rev Endocrinol 2011; 8: 172-82. [CrossRef]

(40.) Heinrichs C, Bourdoux P, Saussez C, Vis HL, Bourguignon JP. Blood spot follicle-stimulating hormone during early postnatal life in normal girls and Turner's syndrome. J Clin Endocrinol Metab 1994; 78: 978-81. [CrossRef]

(41.) Sedin G, Bergquist C, Lindgren G. Ovarian hyperstimulation syndrome in preterm infants. Pediatr Res 1985; 19: 548-52. [CrossRef]

(42.) Starzyk J, Wojcik M, Wojtys J, Tomasik P, Mitkowska Z, Pietrzyk JJ. Ovarian hyperstimulation syndrome in newborns- a case presentation and literature review. Horm Res 2009; 71: 60-4. [CrossRef]

(43.) Marinkovic M, Rasmussen M, Jones K. Feminizing changes in a prematurely infant. Clin Pediatr 2010; 49: 188-9. [CrossRef]

(44.) Jackson K, Babar G, Ugrasbul F. Extremly minipuberty presenting with vaginal bleeding in a month-old preterm girl. Horm Res 2013; 80: 431.

(45.) Altuntas N, Turkyilmaz C, Yuce O, et al. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report. J Pediatr Endocrinol Metab 2014; 27: 355-8. [CrossRef]

(46.) Eichalal U, Schenker JG. Pathophysiology of ovarian hyperstimulation syndrome-views and ideas. Hum Reprod 1997; 12: 1129-37. [CrossRef]

(47.) Berezowski AT, Machado JC, Mendes MC, Maura MD, Duarte G, Cunha SP. Prenatal diagnosis of fetal ovarian hyperstimulation. Ultrasound Obstet Gynecol 2001; 17: 259-62. [CrossRef]

Selim Kurtoglu (1), Osman Bastug (2)

(1)Division of Pediatric Endocrinology and Neanatology, Erciyes University Faculty of Medicine, Kayseri, Turkey

(2)Division of Neanotology, Erciyes University Faculty of Medicine, Kayseri, Turkey

Address for Correspondence: Osman Bastug, Division of Neanotology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

E-mail: osman.bastug@hotmail.com, drosman76@hotmail.com

Received: 05.05.2014

Accepted: 23.05.2014
Table 1. Gonadotropin levels in female newborn babies (RAI)

Days           LH (mIU/L)                 FSH (mIU/L)
         Mean      SD      Median   Mean     SD        Median
 1-5     0.48     0.66     0.20      2      1.37        1.80
06-10    0.45     0.33     0.30     2.44    2.52        1.40
11-15    1.8      1.28     1.60     8.16    4.27        8.95
16-20    1.03     1.39     0.35     1.62    1.05        1.90
21-25    0.46     0.25     0.50     7.07    5.92        3.90
26-28    2.75     2.39     2.80     9.74    9.89        6.15

LH: luteinizing hormone; FSH: follicle stimulating hormone;
SD: standard deviation

Table 2. Gonadotropin levels in male newborn babies (RAI)

Days           LH (mIU/L)                 FSH (mIU/L)
         Mean     SD      Median   Mean       SD      Median
1-5      0.39    0.48      0.20    0.96      0.60      0.85
06-10    2.31    2.29      1.50    2.91      4.38      1.40
11-15    3.55    2.84      2.90    3.71      2.69         3
16-20    4.13    2.76      3.65    2.63      1.45      2.15
21-25    2.86    1.51      2.70    2.50      1.5       2.10
26-28    2.22    2.37      1.40    2.25      0.81      2.40

LH: luteinizing hormone; FSH: follicle stimulating hormone; SD:
standard deviation
COPYRIGHT 2014 AVES
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Invited Review
Author:Kurtoglu, Selim; Bastug, Osman
Publication:Turkish Pediatrics Archive
Article Type:Report
Date:Sep 1, 2014
Words:4071
Previous Article:Vaccination in patients with immunosuppression.
Next Article:The importance of administration of early surfactant and nasal continuous positive airway pressure in newborns with respiratory distress syndrome.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters